Gastric cancer surgery and adjuvant treatment followed by endocrine complications

Patient Info: Anonymized, Female, 40s

After cancer treatment, she was hospitalized with severe nutritional and endocrine complications and improved with hormone replacement and nutritional support.

PubMed CentralRead more →

Breast Cancer: Muriel's Patient Story

Patient Info: Muriel, Female

As of 16 April 2026, Muriel was in the antihormonal-therapy phase, living largely symptom-free after breast surgery and chemotherapy, and supporting other people with cancer as a peer counselor.

Stage IV squamous lung cancer with steroid-refractory immune-related gastritis after pembrolizumab

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: Gastric biopsy during immune gastritis showed CD8-positive lymphocyte inflammation, no cancer

After about 2 years of carboplatin, pemetrexed, and pembrolizumab, lung cancer treatment was stopped because of tumor growth; the later immune-related gastritis improved after escalation to infliximab, while the cancer course remained a setback/progression story.

PubMed CentralRead more →

Stage IV AFP-producing gastric cancer responds to chemotherapy and immunotherapy

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: HER2-negative; pMMR; elevated AFP

Metastatic Site: liver|peritoneum

Imaging showed a sustained partial response, his AFP level returned to normal, and he continued maintenance serplulimab at the latest follow-up.

PubMed CentralRead more →

Stage II Lung Cancer: Michelle's Patient Story

Patient Info: Michelle, Female | Stage II

Receiving ongoing adjuvant treatment after lung cancer first thought to be Stage I was upgraded to Stage IIB because 3 of 18 lymph nodes were positive.

The Patient StoryRead more →

Stage II Breast Cancer: Marina's Survivor Story

Patient Info: Marina, Female | Stage II

Stage II breast cancer survivor after chemotherapy, with ongoing survivorship advice focused on hair loss, neuropathy, fertility preservation, nausea, fatigue, chemo brain, and support.

The Patient StoryRead more →

Stage IV Breast Cancer: Erica's Patient Story

Patient Info: Erica, Female, 40s | Stage IV

Biomarkers: Hormone-positive; HER2-negative

Metastatic Site: Bone — ribs, sternum, spine, femur/right hip, shoulder…

Living with stable Stage IV hormone-positive, HER2-negative metastatic breast cancer involving multiple bones, currently managed with monthly hormone-suppressant injections and monitoring.

The Patient StoryRead more →

Stage IV Melanoma: Ken's Survivor Story

Patient Info: Ken Herich, Male, 60s | Stage IV

Metastatic Site: Abdomen; shinbone/bone; near lungs

After Stage IV melanoma progressed on prior immunotherapies, TIL therapy produced a complete response; as of April 2026, scans showed no evidence of disease and no sign of melanoma returning nearly 1 year after treatment.

City of HopeRead more →

Invasive Lobular Carcinoma: Liz's Survivor Story

Patient Info: Liz O’Riordan, Female, 40s

Technically cancer-free after 2 local recurrences, with no metastatic disease stated, while continuing lifelong monthly injection treatment to reduce the risk of metastatic disease and living with scanxiety.

The Patient StoryRead more →

Stage III lung cancer treatment complicated by immune-related lung inflammation

Patient Info: Anonymized, Male, 60s | Stage III

Biomarkers: EGFR-negative; ALK-negative; ROS1-negative

Mediastinal lymph nodes later enlarged despite additional systemic treatment, prompting radiation and further therapy.

PubMed CentralRead more →

Stage IV lung cancer response followed by immune-related lung inflammation

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: EGFR-negative; ALK-negative; ROS1-negative

Metastatic Site: pleura

After the lung inflammation improved, he did not resume tumor-directed chemotherapy, immunotherapy, or radiation and remained generally well.

PubMed CentralRead more →

Stage IV EGFR Lung Cancer: Kelsey's Patient Story

Patient Info: Kelsey, Female, Under 40 | Stage IV

Biomarkers: EGFR mutation; later ALK mutation after progression

Metastatic Site: Bone — pelvis and spine/L5

Living with Stage IV lung cancer on a clinical trial after progression, with current treatment described as working and quality of life improved.

The Patient StoryRead more →

Stage II EGFR Non-Small Cell Lung Cancer: Daniel's Patient Story

Patient Info: Daniel West, Male, 50s | Stage II

Biomarkers: EGFR positive

As of April 2026, Daniel had shown no evidence of active disease for more than 2 years, while remaining on daily osimertinib through June 2026 and receiving checkups and scans every 3 months for stable monitored lung nodules.

MD AndersonRead more →

Triple-Negative Breast Cancer: Jes's Survivor Story

Patient Info: Jes, Female

Biomarkers: ER-negative; PR-negative; HER2-negative

No evidence of disease after chemotherapy/immunotherapy and bilateral mastectomy; no positive lymph nodes were found, chemotherapy cleared the cancer, and radiation was not needed, though she continued to experience long-term treatment effects.

The Patient StoryRead more →

My STAGE 4 Colon Cancer was Revealed by a Routine Blood Test! (NO SYMPTOMS!)

Patient Info: Jim, Male, 40s | Stage IV

Metastatic Site: Liver; lungs

Stage IV colon cancer with liver and lung metastases responded strongly to FOLFIRINOX-based chemotherapy, with tumor reduction over 70%, no detectable lung cancer on testing, and ongoing maintenance chemotherapy for remaining liver disease.

The Patient StoryRead more →

Ovarian Cancer: Hope's Patient Story

Patient Info: Hope Aguilar, female

More than 14 years after her December 2011 diagnosis, Hope is a survivor and advocate after initial treatment and a later ovarian-cancer recurrence.

Metastatic HER2-positive breast cancer complicated by severe low magnesium

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: HER2-positive

Metastatic Site: bone|lungs|liver|brain

She died during a hospitalization for advanced metastatic breast cancer and severe treatment-related hypomagnesemia, with her final care focused on comfort.

PubMed CentralRead more →

Synchronous Stage IA lung adenocarcinoma and grade 4 glioblastoma: lung nodule regressed during brain-cancer therapy

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: Lung molecular biomarkers not reported; glioblastoma biomarker details not summarized in library fields

The Stage IA lung adenocarcinoma was monitored without lung-directed therapy and decreased from 18 mm to 9 mm while CNS-directed glioblastoma treatment continued; she remained alive with no lung cancer progression.

PubMed CentralRead more →

Hormone receptor-positive high-grade encapsulated papillary breast carcinoma with limited invasion

Patient Info: Anonymized, Female, 40s

Biomarkers: ER/PR-positive, HER2-negative breast cancer; Ki-67 high in papillary/high-grade invasive areas; sentinel lymph nodes negative.

After mastectomy, sentinel-node evaluation, S-1, and endocrine therapy, she remained disease-free and in good health under regular follow-up.

PubMed CentralRead more →

Triple-Negative Breast Cancer: Marina's Survivor Story

Patient Info: Marina, Female, Under 40

Biomarkers: BRCA1 mutation; triple-negative breast cancer

Triple-negative breast cancer survivor with a BRCA1 mutation who completed treatment after an initial diagnosis and a second diagnosis at the 5-year mark; no formal stage or metastatic disease was stated in the available source text.

The Patient StoryRead more →

Stage IIIA lung adenocarcinoma: major pathological response after neoadjuvant immunochemotherapy, complicated by DILI/TEN

Patient Info: Anonymized, Male, 50s | Stage III

Biomarkers: No lung molecular biomarkers reported

At 23 months after thoracoscopic left upper lobectomy, he was clinically stable with no evidence of tumor recurrence; severe postoperative DILI/TEN had improved after stopping the offending drug and intensive supportive treatment.

PubMed CentralRead more →

Stage III Colorectal Adenocarcinoma: Meagan's Survivor Story

Patient Info: Meagan, Female, Under 40 | Stage III

In remission after surgery and 6 months of FOLFOX for high-risk Stage IIIC sigmoid colon adenocarcinoma, with ongoing 6-month scan monitoring and survivorship challenges including scanxiety and neuropathy.

The Patient StoryRead more →

Recurrent lung adenocarcinoma with isolated pancreatic metastasis: Whipple resection after discordant tumor-origin testing

Patient Info: Anonymized, Female, 70+ | Stage Metastatic/Advanced

Biomarkers: Pancreatic lesion showed KRAS

Metastatic Site: mediastinal lymph node; pancreas

After prior lung surgery, adjuvant chemotherapy, and later chemoradiation for mediastinal nodal recurrence, an isolated pancreatic lesion was resected by Whipple procedure; post-Whipple recurrence status was not yet reported.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Kalei's Patient Story

Patient Info: Kalei, Female | Stage IV

Metastatic Site: Lungs

Living with Stage IV rectal cancer after lung metastases were treated surgically; later imaging raised concern for possible recurrence in the lung and rectal area, but lymph-node biopsy was clear and further workup was ongoing.

The Patient StoryRead more →